Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
TACROLIMUS
Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd.
TACROLIMUS
30 gm
GLENMARK PHARMACEUTICALS LTD
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ 1 TACROZ™ OINTMENT Tacrolimus Ointment 0.1% w/w WHAT IS IN THIS LEAFLET 1. What Tacroz is used for 2. How Tacroz works 3. Before you use Tacroz 4. How to use Tacroz 5. While you are using it Side effects 6. Storage and Disposal of Tacroz 7. Product Description 8. Manufacturer and Product Registration Holder 10. Date of revision WHAT TACROZ IS USED FOR Tacroz is used to treat moderate to severe atopic dermatitis (eczema) in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. Only Tacrolimus 0.03% is used to treat children (2 years of age and older) who failed to respond adequately to conventional therapies such as topical corticosteroids. Tacroz is also used to treat moderate to severe atopic dermatitis (eczema) for the prevention of flares and prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to maximum 6 weeks treatment of twice daily Tacroz ointment. HOW TACROZ WORKS The active substance of Tacroz , tacrolimus monohydrate, is an immunomodulating agent. In atopic dermatitis, an over- reaction of the skin’s immune system causes skin inflammation (itchiness, redness, dryness). Tacroz alters the abnormal immune response and relieves the skin inflammation and the itch. BEFORE YOU USE TACROZ - _When you must not use it _ If you are allergic to tacrolimus or any of the other ingredients of this medicine or to macrolide antibiotics (e.g. azithromycin, clarithromycin, erythromycin). - _Before you start to use it _ Talk to your doctor •If you have liver failure. •If you have any skin malignancies (tumours) or if you have a weakened immune system (immuno-compromised) whatever the cause. •If you have an inherited skin barrier disease such as Netherton’s syndrome, lamellar ichthyosis (extensive scaling of the skin due to a thickening of the outer layer of the skin), o Read the complete document
SPACE FOR PHARMACODE SAME SIZE ARTWORK LEAFLET SIZE: 140 mm x 352 mm PE00000 MY _For the use only of a Registered Medical Practitioner or _ _a Hospital or a Laboratory_ Tacrolimus Ointment 0.1% w/w COMPOSITION 1g of Tacroz Ointment 0.1% w/w contains 1mg of tacrolimus (as tacrolimus monohydrate) PHARMACEUTICAL FORM Ointment. White to slightly yellowish ointment. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS Tacrolimus 0.03% ointment is indicated in adults, adolescents and children from the age of 2 years. Tacrolimus 0.1 % ointment is indicated in adults and adolescents (16 years of age and above) _Flare treatment_ _Adults and adolescents (16 years of age and above)_ Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. _Children (2 years of age and above)_ Treatment of moderate to severe atopic dermatitis in children who failed to respond adequately to conventional therapies such as topical corticosteroids. _Maintenance treatment_ Treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected). POSOLOGY AND METHOD OF ADMINISTRATION Tacrolimus treatment should be initiated by physicians with experience in the diagnosis and treatment of atopic dermatitis. Tacrolimus is available in two strengths, Tacrolimus 0.03% and Tacrolimus 0.1% ointment. Posology _Flare treatment_ Tacrolimus can be used for short-term and intermittent long- term treatment. Treatment should not be continuous on a long-term basis. Tacrolimus treatment should begin at the first appearance of signs and symptoms. Each affected region of the skin should be treated with Tacrolimus until lesion are cleared, almost cle Read the complete document